Related Experiment Video
Updated: Jul 16, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
A role for the scaffolding adapter GAB2 in breast cancer
Mohamed Bentires-Alj1, Susana G Gil, Richard Chan
1Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, NRB 1030, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA. mbentire@bidmc.harvard.edu
Abstract:
The scaffolding adapter GAB2 maps to a region (11q13-14) commonly amplified in human breast cancer, and is overexpressed in breast cancer cell lines and primary tumors, but its functional role in mammary carcinogenesis has remained unexplored. We found that overexpression of GAB2 (Grb2-associated binding protein 2) increases proliferation of MCF10A mammary cells in three-dimensional culture. Coexpression of GAB2 with antiapoptotic oncogenes causes lumenal filling, whereas coexpression with Neu (also known as ErbB2 and HER2) results in an invasive phenotype. These effects of GAB2 are mediated by hyperactivation of the Shp2-Erk pathway. Furthermore, overexpression of Gab2 potentiates, whereas deficiency of Gab2 ameliorates, Neu-evoked breast carcinogenesis in mice. Finally, GAB2 is amplified in some GAB2-overexpressing human breast tumors. Our data suggest that GAB2 may be a key gene within an 11q13 amplicon in human breast cancer and propose a role for overexpression of GAB2 in mammary carcinogenesis. Agents that target GAB2 or GAB2-dependent pathways may be useful for treating breast tumors that overexpress GAB2 or HER2 or both.
Insights
Grb2-associated binding protein 2 (GAB2) overexpression drives breast cancer cell proliferation and invasion. Targeting GAB2 may offer new therapeutic strategies for breast tumors, especially those overexpressing HER2.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The Grb2-associated binding protein 2 (GAB2) gene is located in the 11q13-14 region, frequently amplified in human breast cancer.
- GAB2 is overexpressed in breast cancer cell lines and primary tumors, but its role in mammary carcinogenesis is not well understood.
Purpose of the Study:
- To investigate the functional role of GAB2 in mammary cell proliferation, invasion, and breast carcinogenesis.
- To explore the molecular pathways and therapeutic potential associated with GAB2 in breast cancer.
Main Methods:
- Assessed GAB2 effects on MCF10A mammary cell proliferation in 3D culture.
- Investigated GAB2 coexpression with oncogenes (antiapoptotic and Neu/ErbB2/HER2) to observe cellular phenotypes.
- Analyzed GAB2's impact on Neu-evoked breast carcinogenesis in mouse models.
- Examined GAB2 amplification in human breast tumors.
Main Results:
- GAB2 overexpression increased MCF10A cell proliferation.
- Coexpression of GAB2 with antiapoptotic oncogenes led to lumenal filling; with Neu/HER2, it induced an invasive phenotype.
- GAB2-mediated effects involved Shp2-Erk pathway hyperactivation.
- GAB2 overexpression potentiated, while deficiency ameliorated, Neu-evoked breast carcinogenesis in mice.
- GAB2 amplification was observed in some GAB2-overexpressing human breast tumors.
Conclusions:
- GAB2 may be a key gene in the 11q13 amplicon and plays a significant role in mammary carcinogenesis.
- Overexpression of GAB2 contributes to breast cancer progression.
- Targeting GAB2 or its downstream pathways presents a potential therapeutic strategy for breast tumors overexpressing GAB2 and/or HER2.
More Related Videos
06:27A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies
Published on: August 8, 2019
09:18Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
Published on: April 4, 2025
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...